Clinical trial

Acupuncture Study on Rheumatoid Arthritis, Monitoring Microbiome and Blood

NCT01619176

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-10-01

PhaseNA

Study timeline

Study start (unknown)2012-10-01Date precision: month

Registry last updated2023-11-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

methotrexateDRUG · verified · RxNorm: methotrexate

non-steroidal anti-inflammatory drug (NSAID)DRUG

leflunomideDRUG · verified · RxNorm: leflunomide

methotrexateDRUG · verified · RxNorm: methotrexate

non-steroidal anti-inflammatory drug (NSAID)DRUG

leflunomideDRUG · verified · RxNorm: leflunomide

AcupuncturePROCEDURE

Sponsors & collaborators

Chinese Academy of Scienceslead sponsor

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicinecollaborator

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01619176 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.